EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overview of approved CAR-T products and utility in clinical practice

Shakthi T Bhaskar, Bhagirathbhai Dholaria, Bipin N Savani, Salyka Sengsayadeth, Olalekan Oluwole

Clinical Hematology International · 23.10.2024 · 6 (4)

DOI: 10.46989/001c.124277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Hematology International, online erschienen am 23.10.2024. Verfasst von Shakthi T Bhaskar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicine, Hmatology and Oncology Vanderbilt University Medical Center. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Chimeric antigen receptorT Cellapprovedapproved products

Autor:innen und Institutionen

  • Medicine, Hmatology and Oncology Vanderbilt University Medical Center.
  • Vanderbilt University Medical Center.

Zitieren

APA

Bhaskar, S. T., Dholaria, B., Savani, B. N., Sengsayadeth, S., & Oluwole, O. (2024). Overview of approved CAR-T products and utility in clinical practice. Clinical Hematology International, 6(4). https://doi.org/10.46989/001c.124277

Vancouver

Bhaskar ST, Dholaria B, Savani BN, Sengsayadeth S, Oluwole O. Overview of approved CAR-T products and utility in clinical practice. Clinical Hematology International. 2024;6(4). doi:10.46989/001c.124277

BibTeX
@article{Bhaskar2024,
  author = {Bhaskar, Shakthi T and Dholaria, Bhagirathbhai and Savani, Bipin N and Sengsayadeth, Salyka and Oluwole, Olalekan},
  title = {Overview of approved CAR-T products and utility in clinical practice},
  journal = {Clinical Hematology International},
  year = {2024},
  volume = {6},
  number = {4},
  doi = {10.46989/001c.124277}
}
Kostenlos starten →